SMT C1100 - Ezutromid | BMN-195

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 2481

CAS [945531-77-1]

MF C19H15NO3S
MW 337.39

  • Purity: 99%
  • Soluble in DMSO

SMT C1100

Description

Orally active, non-toxic upregulator of utrophin production (EC50 value 0.91 µM in a utrophin A promoter H2K cell-based assay with a luciferase reporter readout) for the treatment of Duchenne muscular dystrophy (DMD). What's more, SMT C1100 significantly reduces dystrophin-deficient muscle pathology in vivo.

KEYWORDS: SMT C1100 |  supplier | Utrophin upregulator | Ezutromid | BMN-195 | SMTC1100 | BMN195 | CAS [945531-77-1] | ECM-adhesion | Utrophin | Upregulator | matrix | adhesion | Duchenne | muscular | dystrophy | DMD

Order
Size Unit Price Stock
10 mg €125.00 In Stock
50 mg €450.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...